XML 182 R67.htm IDEA: XBRL DOCUMENT v3.25.0.1
Subsequent Events - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 07, 2024
Feb. 29, 2024
Jan. 31, 2024
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
May 15, 2023
Subsequent Event [Line Items]                      
Percentage of workforce reduction     95.00%                
Lease obligations remaining       $ 0   $ 2,600,000 $ 600,000 $ 7,700,000 $ 9,700,000 $ 6,600,000  
Common stock, par value       $ 0.0001     $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, par value       $ 0.0001     $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001
2024 SOW under the DMS Agreement | Forecast                      
Subsequent Event [Line Items]                      
Lease obligations remaining         $ 2,900,000            
Subsequent Event                      
Subsequent Event [Line Items]                      
Percentage of workforce reduction     95.00%                
Personnel-related restructuring charges     $ 10,000,000                
Decrease in lease payments   $ 5,700,000                  
Subsequent Event | Merger Agreement                      
Subsequent Event [Line Items]                      
Merger agreement date Nov. 07, 2024                    
Common stock, par value $ 0.0001                    
Stock option exercise price per share 92                    
Subsequent Event | Kalaris Therapeutics, Inc. | Merger Agreement                      
Subsequent Event [Line Items]                      
Common stock, par value 0.00001                    
Preferred stock, par value $ 0.00001                    
Termination fee required to pay $ 3,480,000                    
Termination fee required to receive $ 10,410,000                    
Subsequent Event | Restricted Stock Units                      
Subsequent Event [Line Items]                      
Awards vesting period     4 years